Maria Ochoa-de-Olza

8PUBLICATIONS
102CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 17, 2026
Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

|Feb 02, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.

David Barras, Eleonora Ghisoni, Johanna Chiffelle

|Feb 07, 2023
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics.

Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero

|Sep 24, 2021
A promising platform for predicting toxicity.

Maria Ochoa de Olza

|Sep 04, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.

Fernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza

|Jan 26, 2021
A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.

Marta Ligero, Alonso Garcia-Ruiz, Cristina Viaplana

Pageof 2

Frequent Collaborators

3 joint publications

Clarisse Dromain

3 joint publications

Denarda Dangaj Laniti

3 joint publications

Urania Dafni

3 joint publications

John Prior